ArticleCNS drugs2018

Assessing 'No Evidence of Disease Activity' Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study.

Bianca Weinstock-Guttman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.